CKD
-
Top Health News
FDA Panel Votes on Tenapanor for Hyperphosphatemia in CKD
The Meals and Drug Administration’s (FDA) Cardiovascular and Renal Medicine Advisory Committee voted in favor (9 to 4) of the…
Read More » -
Top Health News
Glycated Albumin Improves Prediction of Opposed CKD Outcomes
Including glycated albumin to HbA1c could enhance glycemic monitoring and danger stratification in sufferers with power kidney illness (CKD), investigators…
Read More » -
Top Health News
Novel Aldosterone Synthase Inhibitor May Improve CKD Remedy
The novel selective aldosterone synthase inhibitor BI 690517 (as much as 10 mg every day) with concurrent renin-angiotensin-system (RAS) inhibition,…
Read More » -
Top Health News
Trabecular Bone Rating Predicts CKD Affected person Skeletal Fragility
Decrease trabecular bone scores (TBS) are related to skeletal fragility throughout the persistent kidney illness (CKD) spectrum, in line with…
Read More » -
Top Health News
Apixaban 5 mg vs 2.5 mg and Increased Bleeding Threat in Atrial Fibrillation With CKD
Amongst sufferers with atrial fibrillation (AF) and extreme persistent kidney illness (CKD), 5-mg apixaban twice day by day, in contrast…
Read More »